Toronto 
Health Canada has approved Pfizer-BioNTech’s vaccine for children of ages five to eleven.
Jesse Paul on Unsplash
Comirnaty or Pfizer-BioNTech’s COVID-19 vaccine is the first COVID-19 vaccine authorized in Canada for use for young kids.
Pfizer vaccine will be administered three weeks apart in a two-dose regimen of 10 micrograms. This is a lower dose than the 30 micrograms two-dose regimen authorized for people 12 years of age and older.
Health Canada said in a news release, “After a thorough and independent scientific review of the evidence, the Department has determined that the benefits of this vaccine for children between 5 and 11 years of age outweigh the risks. ”
Health Canada says the clinical trial showed 90.7% effective at preventing COVID-19 in children 5 to 11 years of age and no serious side effects were identified and that the immune response in children 5 to 11 years of age was comparable to the immune response in people 16 to 25 years of age.
Pfizer-BioNTech’s COVID-19 vaccine was initially authorized for use in people 16 years of age and older on December 9, 2020, and subsequently authorized for children 12 to 15 years of age on May 5, 2021.
